Efavirenz-based versus nevirapine-based antiretroviral therapy among HIV-infected patients receiving rifampin [rifampicin]

Trial Profile

Efavirenz-based versus nevirapine-based antiretroviral therapy among HIV-infected patients receiving rifampin [rifampicin]

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Nov 2011

At a glance

  • Drugs Efavirenz (Primary) ; Nevirapine (Primary) ; Lamivudine; Rifampicin; Stavudine
  • Indications HIV infections; HIV-1 infections; Tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Aug 2009 Status changed from recruiting to completed.
    • 15 Jun 2009 Status change from recruiting to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top